Accreditation

The pipeline is UKAS accredited against ISO 15189:2022 as detailed in Genomics England’s Schedule of Accreditation.

This schedule includes Fixed Scope and Flexible Scope permissions; the latter allows Genomics England to make changes within defined and agreed UKAS boundaries and report the results as accredited. Any results reported that are outside the Fixed Schedule and Flexible Scope boundaries are noted in the statement of limitations and highlighted as outside the scope of UKAS accreditation.

Further detailed information of changes made to the bioinformatics pipeline are summarised in the release notes and in the relevant Rare Disease Genome Analysis Guide for each software version.